Table 2.
MSI Status | Number | %* |
---|---|---|
MSI-Low | 6 | 3.0 |
MSI-Stable | 143 | 71.9 |
MSI-High | 50 | 25.1 |
| ||
IHC Result | ||
| ||
Intact MLH1, MSH2, MSH6, PMS2 | 146 | 72.6 |
Loss of MLH1 & PMS2 | 46 | 22.8 |
With MLH1 methylation | 43 | 93.5 |
Without MLH1 methylation | 3 | 6.5 |
Loss of MSH2 & MSH6 | 2 | 1.0 |
Loss of MSH6 only | 3 | 1.5 |
Loss of PMS2 only | 3 | 1.5 |
Percent of tested endometrial cancers (MSI – 199; Immunohistochemistry – 203)